HLA-B*5801 test ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
38スティーヴンス・ジョンソン症候群1

38. スティーヴンス・ジョンソン症候群


臨床試験数 : 17 薬物数 : 29 - (DrugBank : 9) / 標的遺伝子数 : 15 - 標的パスウェイ数 : 101
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03046914
(ClinicalTrials.gov)
February 24, 20166/2/2017HLA-B*5801 Screening to Prevent Allopurinol-induced Severe Cutaneous Adverse ReactionA Prospective Study to Prove the Usefulness of HLA-B*5801 Screening Test for the Prevention of Allopurinol-induced Severe Cutaneous Adverse Reaction in Patient With Chronic Kidney DiseaseStevens-Johnson Syndrome;Kidney Failure, ChronicGenetic: HLA-B*5801 testSeoul National University HospitalMinistry of Food and Drug Safety, KoreaRecruitingN/AN/AAll600N/AKorea, Republic of